Patient-provider decisions about long-term therapy

American Journal of Managed Care

Volumn 4, Issue 2 SUPPL., 1998, Pages

  Seely, Ellen W ^a   Ravnikar, Veronica A ^a   McClung, Betsy Love ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; BONE MINERAL; BREAST CANCER; CONFERENCE PAPER; DOSE RESPONSE; FOLLOW UP; HEALTH PROGRAM; HORMONAL THERAPY; JOB PERFORMANCE; LIFE SATISFACTION; LONG TERM CARE; MEDICAL DECISION MAKING; OSTEOPOROSIS; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SOCIAL STATUS; UTERUS BLEEDING;

EID: 0031820329     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
2. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
3. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormonal therapy and mortality. N Engl J Med 1997;336: 1769-1775.
4. Lindsay R, Bush TL, Grady D, Speroff L, Lobo RA. Estrogen replacement in menopause. J Clin Endocrinol Metab 1996;81: 3829-3838.
5. Gold DT. The clinical impact of vertebral fractures: Quality of life in women with osteoporosis. Bone 1996;18:185S-189S.
6. Lydick E, Zimmerman SI, Yawn B, et al. Development and validation of a discriminative quality of life questionnaire for osteoporosis (The OPTQoL). J Bone Miner Res 1997;12:456-463.
7. Silverman SL, Cranney A. Quality of life measurement in osteoporosis. J Rheumatol 1997;24:1218-1221.
8. Lips P, Cooper C, Agnusdei D, et al. Quality of life as outcome in the treatment of osteoporosis: The development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporosis Int 1997;7:36-38.
9. Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: A randomized trial. Obstet Gynecol 1997;89:321-325.
10. Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990-995.
11. Cummings SR, Browner WS, Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med 1990; 113:565-567.
12. Holt LH, Taft LB, Moulthrup JM. Bone density measurement: Survey of use and impact on treatment. Menopause 1997;4:219-224.
13. Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140-1147.
14. Nachtigall LE. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 1990;75 (suppl):77S-80S.
15. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-171.
16. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133-136.
17. Dören M, Schneider HPG. The impact of different HRT regimens on compliance. Int J Fertil 1996;41:29-39.
18. Suarez-Almazor M, Homik JE, Messina D, Davis P. Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis. J Bone Miner Res 1997;12:1100-1107.